Pett, Sarah L <br/><br/>
A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection.  [electronic resource] 

 -  AIDS research and human retroviruses  Jun 2010 
 - 653-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1931-8405 
<br/><br/><label>Standard No.: </label>10.1089/aid.2009.0278  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>CCR5 Receptor Antagonists<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Cytomegalovirus--immunology<br/>Dendritic Cells--drug effects<br/>HIV Infections--drug therapy<br/>Herpesvirus 1, Human--immunology<br/>Humans<br/>Leukocyte Count<br/>Male<br/>Middle Aged<br/>Mycobacterium tuberculosis--immunology<br/>T-Lymphocyte Subsets--drug effects<br/>Viral Load